4.6 Article

Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network

Journal

AMERICAN JOURNAL OF PSYCHIATRY
Volume 173, Issue 10, Pages 1015-1023

Publisher

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2016.15091119

Keywords

-

Categories

Funding

  1. Stanley Medical Research Institute
  2. Merck
  3. Sunovion
  4. AztraZeneca
  5. H Lundbeck
  6. Elan Pharma International
  7. NIMH
  8. VA Cooperative Studies Program
  9. AssureRx Health
  10. Janssen
  11. Mayo Foundation
  12. Myriad
  13. National Institute on Alcohol Abuse and Alcoholism
  14. Pfizer
  15. Agency for Heatthcare Research and Quality
  16. Alkermes
  17. AstraZeneca
  18. Cephalon
  19. Eli Lilly
  20. Forest
  21. Marriott Foundation
  22. Naurex
  23. Orexigen
  24. Shire
  25. Takeda
  26. Transcept
  27. Johnson Johnson
  28. National Institute for Health Research
  29. Medical Research Council
  30. Northumberland
  31. Tyne
  32. Wear National Health Service Foundation Trust
  33. Otsuka Pharmaceuticals
  34. American College of Psychiatrists
  35. GlaxoSmithKline
  36. Ferrer
  37. Janssen-Cilag
  38. Lundbeck
  39. Otsuka
  40. Servier

Ask authors/readers for more resources

Objective: DSM-5 introduced the with mixed features specifier for major depressive episodes. The authors assessed the prevalence and phenomenology of mixed depression among bipolar disorder patients and qualitatively compared a range of diagnostic thresholds for mixed depression. Method: In a naturalistic study, 907 adult outpatients with bipolar disorder participating in the Stanley Foundation Bipolar Network were followed longitudinally across 14,310 visits from 1995 to 2002. The Inventory of Depressive Symptomatology-Clinician-Rated Version (IDS-C) and the Young Mania Rating Scale (YMRS) were administered at each visit. Results: Mixed depression, defined as an IDS-C score >= 15 and a YMRS score >2 and <12 at the same visit, was observed in 2,139 visits (14.9% of total visits, and 43.5% of visits with depression) by 584 patients (64.4% of all patients). Women were significantly more Likely than men to experience subthreshold hypomania during visits with depression (40.7% compared with 34.4%). Patients with one or more mixed depression visits had more symptomatic visits and fewer euthymic visits compared with those with no mixed depression visits. DSM-5-based definitions of mixed depression (ranging from narrower definitions requiring >= 3 non overlapping YMRS items concurrent with an IDS-C score >= 15 to broader definitions requiring >= 2 nonoverlapping YMRS items) yielded lower mixed depression prevalence rates (6.3% and 10.8% of visits, respectively) but were found to have similar relationships to gender and longitudinal symptom severity. Conclusions: Among outpatients with bipolar disorder, concurrent hypomanic symptoms observed during visits with depression were common, particularly in women. The DSM-5 diagnostic criteria for depression with mixed features may yield inadequate sensitivity to detect patients with mixed depression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available